Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.
Phung MT, Lee AW, Wu AH, Berchuck A, Cho KR, Cramer DW, Doherty JA, Goodman MT, Hanley GE, Harris HR, McLean K, Modugno F, Moysich KB, Mukherjee B, Schildkraut JM, Terry KL, Titus LJ, Jordan SJ, Webb PM, Pike MC, Pearce CL; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group and the Ovarian Cancer Association Consortium; Ovarian Cancer Association Consortium.
Phung MT, et al. Among authors: harris hr.
Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):927-935. doi: 10.1158/1055-9965.EPI-20-1355. Epub 2021 Feb 22.
Cancer Epidemiol Biomarkers Prev. 2021.
PMID: 33619020
Free PMC article.